List of Tables
Table 1. Safety Lancets for Diabetes Market Trends
Table 2. Safety Lancets for Diabetes Market Drivers & Opportunity
Table 3. Safety Lancets for Diabetes Market Challenges
Table 4. Safety Lancets for Diabetes Market Restraints
Table 5. Global Safety Lancets for Diabetes Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Safety Lancets for Diabetes Revenue Market Share by Company (2019-2024)
Table 7. Global Safety Lancets for Diabetes Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Safety Lancets for Diabetes Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Safety Lancets for Diabetes Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Safety Lancets for Diabetes Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Safety Lancets for Diabetes Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Safety Lancets for Diabetes
Table 13. Global Safety Lancets for Diabetes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Lancets for Diabetes as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Safety Lancets for Diabetes Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Safety Lancets for Diabetes Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Safety Lancets for Diabetes Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Safety Lancets for Diabetes Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Safety Lancets for Diabetes Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Safety Lancets for Diabetes Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Safety Lancets for Diabetes Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Safety Lancets for Diabetes Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Safety Lancets for Diabetes Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Safety Lancets for Diabetes Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Safety Lancets for Diabetes Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Safety Lancets for Diabetes Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Safety Lancets for Diabetes Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Safety Lancets for Diabetes Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Safety Lancets for Diabetes Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Safety Lancets for Diabetes Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Safety Lancets for Diabetes Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Safety Lancets for Diabetes Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Safety Lancets for Diabetes Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Safety Lancets for Diabetes Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Safety Lancets for Diabetes Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Safety Lancets for Diabetes Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Safety Lancets for Diabetes Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Safety Lancets for Diabetes Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Safety Lancets for Diabetes Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Safety Lancets for Diabetes Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Safety Lancets for Diabetes Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Safety Lancets for Diabetes Sales Value by Region (2019-2024) & (%)
Table 44. Global Safety Lancets for Diabetes Sales Value by Region (2025-2030) & (%)
Table 45. Global Safety Lancets for Diabetes Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Safety Lancets for Diabetes Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Safety Lancets for Diabetes Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Safety Lancets for Diabetes Sales Volume by Region (2019-2024) & (%)
Table 49. Global Safety Lancets for Diabetes Sales Volume by Region (2025-2030) & (%)
Table 50. Global Safety Lancets for Diabetes Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Safety Lancets for Diabetes Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Safety Lancets for Diabetes Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Safety Lancets for Diabetes Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Safety Lancets for Diabetes Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Safety Lancets for Diabetes Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Safety Lancets for Diabetes Sales Volume, (2025-2030) & (K Units)
Table 57. Roche Company Information
Table 58. Roche Introduction and Business Overview
Table 59. Roche Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Roche Safety Lancets for Diabetes Product Offerings
Table 61. Roche Recent Development
Table 62. BD Company Information
Table 63. BD Introduction and Business Overview
Table 64. BD Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. BD Safety Lancets for Diabetes Product Offerings
Table 66. BD Recent Development
Table 67. Ascensia Company Information
Table 68. Ascensia Introduction and Business Overview
Table 69. Ascensia Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Ascensia Safety Lancets for Diabetes Product Offerings
Table 71. Ascensia Recent Development
Table 72. Lifescan Company Information
Table 73. Lifescan Introduction and Business Overview
Table 74. Lifescan Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Lifescan Safety Lancets for Diabetes Product Offerings
Table 76. Lifescan Recent Development
Table 77. B. Braun Company Information
Table 78. B. Braun Introduction and Business Overview
Table 79. B. Braun Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. B. Braun Safety Lancets for Diabetes Product Offerings
Table 81. B. Braun Recent Development
Table 82. Terumo Company Information
Table 83. Terumo Introduction and Business Overview
Table 84. Terumo Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Terumo Safety Lancets for Diabetes Product Offerings
Table 86. Terumo Recent Development
Table 87. Nipro Company Information
Table 88. Nipro Introduction and Business Overview
Table 89. Nipro Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Nipro Safety Lancets for Diabetes Product Offerings
Table 91. Nipro Recent Development
Table 92. Cardinal Health Company Information
Table 93. Cardinal Health Introduction and Business Overview
Table 94. Cardinal Health Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Cardinal Health Safety Lancets for Diabetes Product Offerings
Table 96. Cardinal Health Recent Development
Table 97. ARKRAY Company Information
Table 98. ARKRAY Introduction and Business Overview
Table 99. ARKRAY Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. ARKRAY Safety Lancets for Diabetes Product Offerings
Table 101. ARKRAY Recent Development
Table 102. ICU Medical Company Information
Table 103. ICU Medical Introduction and Business Overview
Table 104. ICU Medical Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. ICU Medical Safety Lancets for Diabetes Product Offerings
Table 106. ICU Medical Recent Development
Table 107. Owen Mumford Company Information
Table 108. Owen Mumford Introduction and Business Overview
Table 109. Owen Mumford Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Owen Mumford Safety Lancets for Diabetes Product Offerings
Table 111. Owen Mumford Recent Development
Table 112. HemoCue Company Information
Table 113. HemoCue Introduction and Business Overview
Table 114. HemoCue Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. HemoCue Safety Lancets for Diabetes Product Offerings
Table 116. HemoCue Recent Development
Table 117. Greiner Bio One Company Information
Table 118. Greiner Bio One Introduction and Business Overview
Table 119. Greiner Bio One Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Greiner Bio One Safety Lancets for Diabetes Product Offerings
Table 121. Greiner Bio One Recent Development
Table 122. HTL-STREFA Company Information
Table 123. HTL-STREFA Introduction and Business Overview
Table 124. HTL-STREFA Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. HTL-STREFA Safety Lancets for Diabetes Product Offerings
Table 126. HTL-STREFA Recent Development
Table 127. Sarstedt Company Information
Table 128. Sarstedt Introduction and Business Overview
Table 129. Sarstedt Safety Lancets for Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Sarstedt Safety Lancets for Diabetes Product Offerings
Table 131. Sarstedt Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Safety Lancets for Diabetes Downstream Customers
Table 135. Safety Lancets for Diabetes Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Safety Lancets for Diabetes Product Picture
Figure 2. Global Safety Lancets for Diabetes Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Safety Lancets for Diabetes Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Safety Lancets for Diabetes Sales Volume (2019-2030) & (K Units)
Figure 5. Global Safety Lancets for Diabetes Sales Price (2019-2030) & (US$/Unit)
Figure 6. Safety Lancets for Diabetes Report Years Considered
Figure 7. Global Safety Lancets for Diabetes Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Safety Lancets for Diabetes Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Safety Lancets for Diabetes Revenue in 2023
Figure 10. Safety Lancets for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Safety Lancets with Needle Picture
Figure 12. Safety Lancets with Blade Picture
Figure 13. Global Safety Lancets for Diabetes Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Safety Lancets for Diabetes Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Safety Lancets for Diabetes Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Safety Lancets for Diabetes Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Safety Lancets for Diabetes Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital & Clinics
Figure 19. Product Picture of Home
Figure 20. Product Picture of Other
Figure 21. Global Safety Lancets for Diabetes Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Safety Lancets for Diabetes Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Safety Lancets for Diabetes Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Safety Lancets for Diabetes Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Safety Lancets for Diabetes Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Safety Lancets for Diabetes Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Safety Lancets for Diabetes Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Safety Lancets for Diabetes Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Safety Lancets for Diabetes Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Safety Lancets for Diabetes Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Safety Lancets for Diabetes Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Safety Lancets for Diabetes Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Safety Lancets for Diabetes Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Safety Lancets for Diabetes Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Safety Lancets for Diabetes Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Safety Lancets for Diabetes Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Safety Lancets for Diabetes Sales Volume (%), (2019-2030)
Figure 38. United States Safety Lancets for Diabetes Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Safety Lancets for Diabetes Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Safety Lancets for Diabetes Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Safety Lancets for Diabetes Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Safety Lancets for Diabetes Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Safety Lancets for Diabetes Sales Value by Application (%), 2023 VS 2030
Figure 44. China Safety Lancets for Diabetes Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Safety Lancets for Diabetes Sales Value by Type (%), 2023 VS 2030
Figure 46. China Safety Lancets for Diabetes Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Safety Lancets for Diabetes Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Safety Lancets for Diabetes Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Safety Lancets for Diabetes Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Safety Lancets for Diabetes Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Safety Lancets for Diabetes Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Safety Lancets for Diabetes Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Safety Lancets for Diabetes Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Safety Lancets for Diabetes Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Safety Lancets for Diabetes Sales Value by Application (%), 2023 VS 2030
Figure 56. India Safety Lancets for Diabetes Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Safety Lancets for Diabetes Sales Value by Type (%), 2023 VS 2030
Figure 58. India Safety Lancets for Diabetes Sales Value by Application (%), 2023 VS 2030
Figure 59. Safety Lancets for Diabetes Industrial Chain
Figure 60. Safety Lancets for Diabetes Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
